KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moderna (MRNA) Change in Inventory: 2020-2025

Historic Change in Inventory for Moderna (MRNA) over the last 5 years, with Sep 2025 value amounting to $91.0 million.

  • Moderna's Change in Inventory rose 727.27% to $91.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$78.0 million, marking a year-over-year decrease of 1.30%. This contributed to the annual value of -$83.0 million for FY2024, which is 88.89% up from last year.
  • According to the latest figures from Q3 2025, Moderna's Change in Inventory is $91.0 million, which was down 20.18% from $114.0 million recorded in Q2 2025.
  • In the past 5 years, Moderna's Change in Inventory registered a high of $501.0 million during Q1 2022, and its lowest value of -$1.1 billion during Q4 2022.
  • For the 3-year period, Moderna's Change in Inventory averaged around -$56.1 million, with its median value being $8.0 million (2025).
  • Per our database at Business Quant, Moderna's Change in Inventory spiked by 912.77% in 2021 and then crashed by 336.97% in 2022.
  • Quarterly analysis of 5 years shows Moderna's Change in Inventory stood at $476.0 million in 2021, then tumbled by 336.97% to -$1.1 billion in 2022, then spiked by 74.73% to -$285.0 million in 2023, then declined by 2.11% to -$291.0 million in 2024, then spiked by 727.27% to $91.0 million in 2025.
  • Its last three reported values are $91.0 million in Q3 2025, $114.0 million for Q2 2025, and $8.0 million during Q1 2025.